Gentherm Inc

THRM remains in a Stage 2 advancing uptrend but is showing a Bullish Exhaustion inflection at recent highs. Momentum has flattened and price is retracing into the rising short‐ and intermediate EMAs. While the medium‐term bias stays bullish under Stage 2, execution is deferred until a pullback is absorbed near key EMAs and the 50‐day SMA.

• ↑Q1 2026 revenue $394M, +11.3% YoY; secured $395M in new business awards
• ↑Adjusted EBITDA margin rose to 12.5%, driven by 140 bp of operating leverage
• ↓Weak profitability factors; material cost inflation drove margin decline